INHIBIKASE THERAPEUTICS

Inhibikase Therapeutics has developed the first small molecule platform capable of treating both bacterial and viral infectious disease through a common mechanism of action in the host. The Company's host targeting strategy creates multi-pathogen anti-infectives without stimulating resistance.

INHIBIKASE THERAPEUTICS

Industry:

Health Care Health Diagnostics Therapeutics

Founded:

2008-01-01

Address:

Atlanta, Georgia, United States

Country:

United States

Website Url:

http://www.inhibikase.com

Total Employee:

51+

Status:

Active

Contact:

617-936-0184

Total Funding:

1.27 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics

Similar Organizations

geneos-therapeutics-logo

Geneos Therapeutics

Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.

tiburio-therapeutics-logo

Tiburio Therapeutics

Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.

Current Advisors List

paul-grint_image

Paul Grint Board Member @ Inhibikase Therapeutics
Board_member
2019-01-01

Current Employees Featured

not_available_image

Martin Joyce
Martin Joyce Chief Financial Officer @ Inhibikase Therapeutics
Chief Financial Officer

milton-werner_image

Milton Werner
Milton Werner Founder, President & CEO @ Inhibikase Therapeutics
Founder, President & CEO
2008-08-01

Founder

milton-werner_image

Milton Werner

Stock Details

Company's stock symbol is NASDAQ:IKT

Investors List

national-institute-of-neurological-disorders-and-stroke_image

Official Site Inspections

http://www.inhibikase.com Semrush global rank: 5.16 M Semrush visits lastest month: 1.56 K

Host Informations
Whois Informations

Loading ...